加拿大扩大国内等离子体收集,以促进免疫球蛋白供应,减少对外国来源的依赖。 Canada expands domestic plasma collection to boost immunoglobulin supply and reduce reliance on foreign sources.

加拿大血液服务局正在扩大国内等离子体的收集和制造,以减少对免疫球蛋白依赖美国和欧洲来源,免疫球蛋白是治疗免疫紊乱和癌症患者的关键手段。 Canadian Blood Services is expanding domestic plasma collection and manufacturing to reduce reliance on U.S. and European sources for immunoglobulin, a critical treatment for immune disorders and cancer patients. 加拿大至少一半的免疫球蛋白来自国内血浆, The goal is for at least half of Canada’s immunoglobulin to come from domestic plasma by strengthening local donation programs and partnering with global manufacturers. 这项工作的目的是在需求不断增长和国际不确定的情况下加强供应链的复原力,为符合条件的加拿大人提供更多捐助机会。 The effort aims to bolster supply chain resilience amid rising demand and international uncertainties, with increased donation opportunities for eligible Canadians.